Compare Aditya Birla Sun Life Pharma & Healthcare Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Risk
Very High
Very High
Rating
2.0
5.0
Min SIP Amount
₹100
₹100
Expense Ratio
2.3
1.87
NAV
₹30.64
₹37.27
Fund Started
20 Jun 2019
25 Jun 2018
Fund Size
₹854.04 Cr
₹6801.16 Cr
Exit Load
Exit load of 1% if redeemed within 30 days.
Exit load of 1% if redeemed within 15 days.
1 Year
8.42%
6.03%
3 Year
23.93%
26.98%
5 Year
14.48%
17.15%
Equity
98.45%
97.98%
Cash
1.55%
1.99%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 13.34% |
Apollo Hospitals Enterprise Ltd. | 7.78% |
Torrent Pharmaceuticals Ltd. | 5.20% |
JB Chemicals & Pharmaceuticals Ltd. | 4.99% |
Ajanta Pharma Ltd. | 4.53% |
Lupin Ltd. | 4.21% |
Fortis Healthcare Ltd. | 4.17% |
Aurobindo Pharma Ltd. | 4.16% |
Abbott India Ltd. | 4.02% |
Ipca Laboratories Ltd. | 3.94% |
Sun Pharmaceutical Industries Ltd. | 11.21% |
Cipla Ltd. | 9.40% |
Mankind Pharma Ltd. | 7.64% |
Dr. Reddy's Laboratories Ltd. | 6.52% |
Biocon Ltd. | 6.20% |
Divi's Laboratories Ltd. | 5.95% |
Lupin Ltd. | 3.99% |
Aurobindo Pharma Ltd. | 3.70% |
Alkem Laboratories Ltd. | 3.47% |
Syngene International Ltd. | 3.16% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
20 Jun 2019
25 Jun 2018
